Sfoglia per AUTORE
SAGLIO G
Collezione AOU San Luigi di Orbassano

  

Items : 84

miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia. in Scientific reports / Sci Rep. 2024 Jul 2;14(1):15089. doi: 10.1038/s41598-024-65404-7.
2024
AOU San Luigi di Orbassano

Poggio P; Rocca S; Fusella F; Ferretti R; Ala U; D'Anna F; Giugliano E; Panuzzo C; Fontana D; Palumbo V; Carrà G; Taverna D; Gambacorti-Passerini C; Saglio G; Fava C; Piazza R; Morotti A; Orso F; Brancaccio M;

Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study. in Haematologica / Haematologica. 2022 Oct 1;107(10):2356-2364. doi: 10.3324/haematol.2021.280175.
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Soverini S; Albano F; Simula MP; Sorà F; Porretto F; Cavazzini F; Cedrone M; Trabacchi E; Bocchia M; Martino B; Tiribelli M; Rege-Cambrin G; Stagno F; D'Adda M; Salvucci M; Intermesoli T; Levato L; Breccia M; Castagnetti F; Gugliotta G; Foà R; Pane F; Cavo M; Saglio G; Baccarani M; Rosti G;

Detection of SF3B1 p.Lys700Glu Mutation by PNA-PCR Clamping in Myelodysplastic Syndromes and Myeloproliferative Neoplasms. in Journal of clinical medicine / J Clin Med. 2022 Feb 25;11(5):1267. doi: 10.3390/jcm11051267.
2022
AOU San Luigi di Orbassano

Petiti J; Itri F; Signorino E; Frolli A; Fava C; Armenio M; Marini S; Giugliano E; Lo Iacono M; Saglio G; Cilloni D;

COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report. in British journal of haematology / Br J Haematol. 2022 Feb;196(3):559-565. doi: 10.1111/bjh.17890. Epub 2021 Oct 11.
2022
AO Cuneo
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Saglio G; Tiribelli M; Foà R; Stagno F; Tafuri A; Sorà F; Sportoletti P; Russo S; Rita Scortechini A; Sancetta R; Rosti G; Rapezzi D; Rege-Cambrin G; Pregno P; Pizzuti M; Cristina Miggiano M; Luzi D; Malato A; Levato L; Loglisci G; Lucchesi A; Luciano L; Lunghi F; Latagliata R; Leonetti Crescenzi S; La Barba G; Intermesoli T; Iurlo A; Gugliotta G; et alii...

Droplet Digital PCR for BCR-ABL1 Monitoring in Diagnostic Routine: Ready to Start? in Cancers / Cancers (Basel). 2021 Oct 30;13(21):5470. doi: 10.3390/cancers13215470.
2021
AOU San Luigi di Orbassano

Bochicchio MT; Petiti J; Berchialla P; Izzo B; Giugliano E; Ottaviani E; Errichiello S; Rege-Cambrin G; Venturi C; Luciano L; Daraio F; Calistri D; Rosti G; Saglio G; Martinelli G; Pane F; Cilloni D; Gottardi EM; Fava C;

2021
AOU San Luigi di Orbassano

Fava C; Bernardi S; Gottardi EM; Lorenzatti R; Galeotti L; Ceccherini F; Cordoni F; Daraio F; Giugliano E; Jovanovski A; Petiti J; Varotto M; Barberio D; Rege-Cambrin G; Berchialla P; Sciannameo V; Malagola M; Saglio G; Russo D;

2021
AO Cuneo
ASL Alessandria
AOU San Luigi di Orbassano

Tedeschi A; Festuccia MB; Monforte AD; Capochiani E; Selleri C; Simonetti F; Saracino A; Rapezzi D; Badagliacca MR; Falasca K; Molteni A; Palazzolo R; Schettino G; Bocchia M; Turrini M; Ascierto PA; Paley C; Saglio G; Coco P; D'Alessio A; Zuurman M; Morelli M; Mortara A; Vannucchi AM;

Dosing Strategies for Improving the Risk-Benefit Profile of Ponatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase. in Frontiers in oncology / Front Oncol. 2021 Mar 16;11:642005. doi: 10.3389/fonc.2021.642005. eCollection 2021.
2021
AOU San Luigi di Orbassano

Castagnetti F; Pane F; Rosti G; Saglio G; Breccia M;

Standardization of BCR-ABL1 p210 Monitoring: From Nested to Digital PCR. in Cancers / Cancers (Basel). 2020 Nov 6;12(11):3287. doi: 10.3390/cancers12113287.
2020
AOU San Luigi di Orbassano

Jovanovski A; Petiti J; Giugliano E; Gottardi EM; Saglio G; Cilloni D; Fava C;

2020
AOU San Luigi di Orbassano

Petiti J; Lo Iacono M; Dragani M; Pironi L; Fantino C; Rapanotti MC; Quarantelli F; Izzo B; Divona M; Rege-Cambrin G; Saglio G; Gottardi EM; Cilloni D; Fava C;

Highly Sensitive Detection of IDH2 Mutations in Acute Myeloid Leukemia. in Journal of clinical medicine / J Clin Med. 2020 Jan 19;9(1):271. doi: 10.3390/jcm9010271.
2020
AOU San Luigi di Orbassano

Petiti J; Rosso V; Croce E; Franceschi V; Andreani G; Dragani M; De Gobbi M; Lunghi M; Saglio G; Fava C; Lo Iacono M; Cilloni D;

Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study. in Blood / Blood. 2020 Feb 20;135(8):534-541. doi: 10.1182/blood.2019002969.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Pileri SA; Percesepe A; Laginestra MA; Mignone F; Vigneri P; Pane F; Errichiello S; Saglio G; Serra A; Stella S; Bocchia M; Calistri E; Annunziata M; Musolino C; Attolico I; Girasoli M; Coluzzi S; Capodanno I; Salvucci M; Sancetta R; Abruzzese E; Binotto G; D'Adda M; di Bona E; di Raimondo F; Stagno F; Russo Rossi AV; Albano F; Gugliotta G; et alii...

Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey. in Leukemia / Leukemia. 2020 Aug;34(8):2260-2261. doi: 10.1038/s41375-020-0904-z. Epub 2020 Jun 18.
2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Rosti G; Rege-Cambrin G; Pregno P; Luciano L; Latagliata R; Iurlo A; Gozzini A; Gugliotta G; Galimberti S; Fava C; Castagnetti F; Bonifacio M; Bocchia M; Abruzzese E; Breccia M; Stagno F; Tiribelli M; Foà R; Saglio G; Breccia M; Abruzzese E; Bocchia M; Bonifacio M; Castagnetti F; Fava C; Galimberti S; Gozzini A; Gugliotta G; Iurlo A; et alii...

Clone wars: co-occurrence of IDH2 R140Q and R172K in myelodysplastic syndromes. in Annals of hematology / Ann Hematol. 2020 Apr;99(4):891-893. doi: 10.1007/s00277-020-03913-x. Epub 2020 Feb 4.
2020
AOU San Luigi di Orbassano

Rosso V; Petiti J; Dragani M; Andreani G; Croce E; Lo Iacono M; Saglio G; Fava C; Cilloni D;

Nilotinib in the treatment of chronic myeloid leukemia. in Future oncology (London, England) / Future Oncol. 2019 Mar;15(9):953-965. doi: 10.2217/fon-2018-0468. Epub 2018 Dec 14.
2019
AOU San Luigi di Orbassano

Sacha T; Saglio G;

First-line therapy for chronic phase CML: selecting the optimal BCR-ABL1-targeted TKI. in Leukemia & lymphoma / Leuk Lymphoma. 2018 Jul;59(7):1523-1538. doi: 10.1080/10428194.2017.1379074. Epub 2017 Oct 3.
2018
AOU San Luigi di Orbassano

Jabbour E; Saglio G;

Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series. in Annals of hematology / Ann Hematol. 2018 Jan;97(1):95-100. doi: 10.1007/s00277-017-3144-1. Epub 2017 Oct 2.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Baccarani M; Specchia G; Cortelezzi A; Saglio G; Rosti G; Pane F; Bocchia M; Sica S; Breccia M; Luciano L; Martino B; Rege-Cambrin G; Stagno F; Castagnetti F; Gugliotta G; Tiribelli M; Gozzini A; Pungolino E; Bucelli C; Binotto G; Cattaneo D; Fava C; Orlandi EM; Sorà F; Ferrero D; Pregno P; Latagliata R; Annunziata M; Bonifacio M; et alii...

Dasatinib dose management for the treatment of chronic myeloid leukemia. in Cancer / Cancer. 2018 Apr 15;124(8):1660-1672. doi: 10.1002/cncr.31232. Epub 2018 Jan 25.
2018
AOU San Luigi di Orbassano

Talpaz M; Saglio G; Atallah E; Rousselot P;

Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia. in Haematologica / Haematologica. 2017 Sep;102(9):1530-1536. doi: 10.3324/haematol.2017.169532. Epub 2017 Jun 1.
2017
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Martinelli G; Cavo M; Foà R; Soverini S; Caracciolo C; Bonifacio M; Binotto G; Bigazzi C; Tiribelli M; Sorà F; La Barba G; Martino B; Stagno F; Cavazzini F; D'Adda M; Pregno P; Levato L; Intermesoli T; Abruzzese E; Albano F; Iurlo A; Breccia M; Castagnetti F; Gugliotta G; Pane F; Saglio G; Baccarani M; Rosti G; Gugliotta G; et alii...

Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones. in Oncotarget / Oncotarget. 2017 May 30;8(22):35508-35522. doi: 10.18632/oncotarget.16348.
2017
AOU San Luigi di Orbassano

Carrà G; Panuzzo C; Torti D; Parvis G; Crivellaro S; Familiari U; Volante M; Morena D; Lingua MF; Brancaccio M; Guerrasio A; Pandolfi PP; Saglio G; Taulli R; Morotti A;

5'UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia. in Journal of hematology & oncology / J Hematol Oncol. 2017 Jan 18;10(1):18. doi: 10.1186/s13045-016-0382-y.
2017
AOU San Luigi di Orbassano

Marconi C; Canobbio I; Bozzi V; Pippucci T; Simonetti G; Melazzini F; Angori S; Martinelli G; Saglio G; Torti M; Pastan I; Seri M; Pecci A;

Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes. in British journal of haematology / Br J Haematol. 2017 Feb;176(3):491-495. doi: 10.1111/bjh.13968. Epub 2016 Feb 23.
2017
AOU San Luigi di Orbassano

Di Savino A; Gaidano V; Palmieri A; Crasto F; Volpengo A; Lorenzatti R; Scaravaglio P; Manello A; Nicoli P; Gottardi E; Saglio G; Cilloni D; De Gobbi M;

Mimicking the Acute Myeloid Leukemia Niche for Molecular Study and Drug Screening. in Tissue engineering. Part C, Methods / Tissue Eng Part C Methods. 2017 Feb;23(2):72-85. doi: 10.1089/ten.TEC.2016.0404. Epub 2017 Jan 13.
2017
AOU San Luigi di Orbassano

Houshmand M; Soleimani M; Atashi A; Saglio G; Abdollahi M; Nikougoftar Zarif M;

Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios. in Annals of hematology / Ann Hematol. 2017 Aug;96(8):1303-1313. doi: 10.1007/s00277-017-3012-z. Epub 2017 May 22.
2017
AOU San Luigi di Orbassano

Saglio G; le Coutre P; Cortes J; Mayer J; Rowlings P; Mahon FX; Kroog G; Gooden K; Subar M; Shah NP;

Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 2017 Apr;79(4):767-773. doi: 10.1007/s00280-017-3271-3. Epub 2017 Mar 13
2017
ASL Città di Torino
AOU San Luigi di Orbassano

Petrini M; Danesi R; Arrigoni E; Grassi S; Ciabatti E; Fontanelli G; Guerrini F; Cervetti G; D'Avolio A; Fava C; Baratè C; Di Paolo A; Polillo M; Laurino M; Domingo D; Galeotti L; Ceccherini F; Cornolti F; Saglio G; Galimberti S;

Altered Erythropoiesis in Mouse Models of Type 3 Hemochromatosis. in BioMed research international / Biomed Res Int. 2017;2017:2408941. doi: 10.1155/2017/2408941. Epub 2017 May 2.
2017
AOU San Luigi di Orbassano

Pellegrino RM; Riondato F; Ferbo L; Boero M; Palmieri A; Osella L; Pollicino P; Miniscalco B; Saglio G; Roetto A;

2016
AOU San Luigi di Orbassano

Guaraldo M; Santambrogio P; Rovelli E; Di Savino A; Saglio G; Cittaro D; Roetto A; Levi S;

Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale. in Leukemia / Leukemia. 2016 Sep;30(9):1844-52. doi: 10.1038/leu.2016.90. Epub 2016 Apr 25.
2016
AOU San Luigi di Orbassano

Cross NC; White HE; Ernst T; Welden L; Dietz C; Saglio G; Mahon FX; Wong CC; Zheng D; Wong S; Wang SS; Akiki S; Albano F; Andrikovics H; Anwar J; Balatzenko G; Bendit I; Beveridge J; Boeckx N; Cerveira N; Cheng SM; Colomer D; Czurda S; Daraio F; Dulucq S; Eggen L; El Housni H; Gerrard G; Gniot M; et alii...

Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients. in Haematologica / Haematologica. 2016 Oct;101(10):1200-1207. doi: 10.3324/haematol.2016.144949. Epub 2016 Jul 28.
2016
AOU San Luigi di Orbassano

Castagnetti F; Breccia M; Gugliotta G; Martino B; D'Adda M; Stagno F; Carella AM; Avanzini P; Tiribelli M; Trabacchi E; Visani G; Gobbi M; Salvucci M; Levato L; Binotto G; Capalbo SF; Bochicchio MT; Soverini S; Cavo M; Martinelli G; Alimena G; Pane F; Saglio G; Rosti G; Baccarani M;

Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome. in Oncotarget / Oncotarget. 2016 Nov 29;7(48):80083-80090. doi: 10.18632/oncotarget.11657.
2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Orlandi EM; Galimberti S; Luciano L; Rege-Cambrin G; Sica S; Sorà F; Calistri E; Isidori A; Crugnola M; Giglio G; Celesti F; Spadea A; Mauro E; Avanzini P; Rossi AR; Cedrone M; Cortesi L; Scaffidi L; D'Addosio AM; Storti S; Gugliotta G; Montefusco E; Falzetti F; Russo S; Mansueto G; Binotto G; Cavazzini F; Annunziata M; Vigneri P; et alii...

2016
AOU San Luigi di Orbassano

Crivellaro S; Carrà G; Panuzzo C; Taulli R; Guerrasio A; Saglio G; Morotti A;

Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicity. in Cancer / Cancer. 2016 May 1;122(9):1398-407. doi: 10.1002/cncr.29933. Epub 2016 Mar 21.
2016
AOU San Luigi di Orbassano

Schiffer CA; Cortes JE; Hochhaus A; Saglio G; le Coutre P; Porkka K; Mustjoki S; Mohamed H; Shah NP;

Ponatinib for chronic myeloid leukaemia: future perspectives. in The Lancet. Oncology / Lancet Oncol. 2016 May;17(5):546-7. doi: 10.1016/S1470-2045(16)30064-X. Epub 2016 Apr 12.
2016
AOU San Luigi di Orbassano

Fava C; Saglio G;

Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia. in American journal of hematology / Am J Hematol. 2016 Jun;91(6):617-22. doi: 10.1002/ajh.24362. Epub 2016 Apr 24.
2016
AOU San Luigi di Orbassano

Gugliotta G; Castagnetti F; Breccia M; Gozzini A; Usala E; Carella AM; Rege-Cambrin G; Martino B; Abruzzese E; Albano F; Stagno F; Luciano L; D'Adda M; Bocchia M; Cavazzini F; Tiribelli M; Lunghi M; Pia Falcone A; Musolino C; Levato L; Venturi C; Soverini S; Cavo M; Alimena G; Pane F; Martinelli G; Saglio G; Rosti G; Baccarani M; et alii...

2016
AOU San Luigi di Orbassano

Soverini S; De Benedittis C; Castagnetti F; Gugliotta G; Mancini M; Bavaro L; Machova Polakova K; Linhartova J; Iurlo A; Russo D; Pane F; Saglio G; Rosti G; Cavo M; Baccarani M; Martinelli G;

Transferrin Receptor 2 Dependent Alterations of Brain Iron Metabolism Affect Anxiety Circuits in the Mouse. in Scientific reports / Sci Rep. 2016 Aug 1;6:30725. doi: 10.1038/srep30725.
2016
AOU San Luigi di Orbassano

Pellegrino RM; Boda E; Montarolo F; Boero M; Mezzanotte M; Saglio G; Buffo A; Roetto A;

Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2016 Aug;16 Suppl:S96-S100. doi: 10.1016/j.clml.2016.03.008. Epub 2016 A
2016
AOU San Luigi di Orbassano

Fava C; Rege-Cambrin G; Dogliotti I; Gottardi E; Berchialla P; Di Gioacchino B; Crasto F; Lorenzatti R; Volpengo A; Daraio F; Fantino C; Saglio G;

A comparative study of myocardial molecular phenotypes of two tfr2? null mice: role in ischemia/reperfusion. in BioFactors (Oxford, England) / Biofactors. 2015 Sep-Oct;41(5):360-71. doi: 10.1002/biof.1237. Epub 2015 Oct 13.
2015
AOU San Luigi di Orbassano

Boero M; Pagliaro P; Tullio F; Pellegrino RM; Palmieri A; Ferbo L; Saglio G; De Gobbi M; Penna C; Roetto A;

Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib. in Leukemia / Leukemia. 2015 Sep;29(9):1823-31. doi: 10.1038/leu.2015.152. Epub 2015 Jun 19.
2015
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Pane F; Martinelli G; Cavo M; Alimena G; Testoni N; Soverini S; Venturi C; Leoni P; Cavazzini F; Rossi G; Gherlinzoni F; Pregno P; Levato L; Intermesoli T; Martino B; Albano F; Abruzzese E; Iurlo A; Stagno F; Breccia M; Gugliotta G; Castagnetti F; Saglio G; Rosti G; Baccarani M;

Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemia. in Haematologica / Haematologica. 2015 Sep;100(9):1146-50. doi: 10.3324/haematol.2015.129221. Epub 2015 Jun 25.
2015
AOU San Luigi di Orbassano

Gugliotta G; Castagnetti F; Breccia M; Levato L; D'Adda M; Stagno F; Tiribelli M; Salvucci M; Fava C; Martino B; Cedrone M; Bocchia M; Trabacchi E; Cavazzini F; Usala E; Russo Rossi A; Bochicchio MT; Soverini S; Alimena G; Cavo M; Pane F; Martinelli G; Saglio G; Baccarani M; Rosti G;

Milestones and monitoring. in Current hematologic malignancy reports / Curr Hematol Malig Rep. 2015 Jun;10(2):167-72. doi: 10.1007/s11899-015-0258-1.
2015
AOU San Luigi di Orbassano

Morotti A; Fava C; Saglio G;

Update on emerging treatments for chronic myeloid leukemia. in Expert opinion on emerging drugs / Expert Opin Emerg Drugs. 2015 Jun;20(2):183-96. doi: 10.1517/14728214.2015.1031217. Epub 2015 Mar 31
2015
AOU San Luigi di Orbassano

Fava C; Morotti A; Dogliotti I; Saglio G; Rege-Cambrin G;

Differences among young adults, adults and elderly chronic myeloid leukemia patients. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Jan;26(1):185-192. doi: 10.1093/annonc/mdu490. Epub 2014 Oct 30.
2015
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Rosti G; Pane F; Saglio G; Martinelli G; Cavo M; Alimena G; de Vivo A; Tiribelli M; Gozzini A; Russo D; Bonifacio M; Gobbi M; Cuneo A; Stagno F; Pregno P; Martino B; Abruzzese E; Rossi G; Iurlo A; Specchia G; Levato L; Baccarani M; Breccia M; Gugliotta G; Castagnetti F;

Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina. in Blood / Blood. 2015 Apr 30;125(18):2771-8. doi: 10.1182/blood-2014-09-601674. Epub 2015 Mar 12.
2015
AOU San Luigi di Orbassano

Wang J; Shen ZX; Saglio G; Jin J; Huang H; Hu Y; Du X; Li J; Meng F; Zhu H; Hu J; Wang J; Hou M; Hertle S; Menssen HD; Ortmann CE; Tribouley C; Yuan Y; Baccarani M; Huang X;

The choice of first-line chronic myelogenous leukemia treatment. in Annals of hematology / Ann Hematol. 2015 Apr;94 Suppl 2(Suppl 2):S123-31. doi: 10.1007/s00277-015-2321-3. Epub 2015 Mar 27.
2015
AOU San Luigi di Orbassano

Fava C; Rege-Cambrin G; Saglio G;

HAUSP compartmentalization in chronic myeloid leukemia. in European journal of haematology / Eur J Haematol. 2015 Apr;94(4):318-21. doi: 10.1111/ejh.12422. Epub 2014 Sep 3.
2015
AOU San Luigi di Orbassano

Morotti A; Panuzzo C; Crivellaro S; Carrà G; Guerrasio A; Saglio G;

BCR-ABL inactivates cytosolic PTEN through Casein Kinase II mediated tail phosphorylation. in Cell cycle (Georgetown, Tex.) / Cell Cycle. 2015;14(7):973-9. doi: 10.1080/15384101.2015.1006970.
2015
AOU San Luigi di Orbassano

Morotti A; Panuzzo C; Crivellaro S; Carrà G; Fava C; Guerrasio A; Pandolfi PP; Saglio G;

2015
AOU San Luigi di Orbassano

Panuzzo C; Volpe G; Cibrario Rocchietti E; Casnici C; Crotta K; Crivellaro S; Carrà G; Lorenzatti R; Peracino B; Torti D; Morotti A; Camacho-Leal MP; Defilippi P; Marelli O; Saglio G;

mTOR pathway activation in multiple myeloma cell lines and primary tumour cells: pomalidomide enhances cytoplasmic-nuclear shuttling of mTOR protein. in Oncoscience / Oncoscience. 2015 Apr 6;2(4):382-94. doi: 10.18632/oncoscience.148. eCollection 2015.
2015
AOU San Luigi di Orbassano

Guglielmelli T; Giugliano E; Brunetto V; Rapa I; Cappia S; Giorcelli J; Rrodhe S; Papotti M; Saglio G;

Kinase-inhibitor-insensitive cancer stem cells in chronic myeloid leukemia. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2014 Mar;14(3):287-99. doi: 10.1517/14712598.2014.867323. Epub 2014 Jan 3.
2014
AOU San Luigi di Orbassano

Morotti A; Panuzzo C; Fava C; Saglio G;

Plasma and intracellular imatinib concentrations in patients with chronic myeloid leukemia. in Therapeutic drug monitoring / Ther Drug Monit. 2014 Jun;36(3):410-2. doi: 10.1097/FTD.0000000000000013.
2014
AOU San Luigi di Orbassano

De Francia S; D?Avolio A; Ariaudo A; Pirro E; Piccione F; Simiele M; Fava C; Calcagno A; Di Perri G; Saglio G;

BCR-ABL promotes PTEN downregulation in chronic myeloid leukemia. in PloS one / PLoS One. 2014 Oct 24;9(10):e110682. doi: 10.1371/journal.pone.0110682. eCollection 2014.
2014
AOU San Luigi di Orbassano

Panuzzo C; Crivellaro S; Carrà G; Guerrasio A; Saglio G; Morotti A;

Chronic myeloid leukemia: state of the art in 2012. in Current oncology reports / Curr Oncol Rep. 2012 Oct;14(5):379-86. doi: 10.1007/s11912-012-0253-9.
2012
AOU San Luigi di Orbassano

Fava C; Rege-Cambrin G; Saglio G;

A new HPLC-UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patients. in Journal of chromatographic science / J Chromatogr Sci. 2011 Nov-Dec;49(10):753-7. doi: 10.1093/chrsci/49.10.753.
2011
AOU San Luigi di Orbassano

Pirro E; De Francia S; De Martino F; Fava C; Ulisciani S; Cambrin GR; Racca S; Saglio G; Di Carlo F;

Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patients. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2011 Apr;47(6):814-8. doi: 10.1016/j.ejca.2010.12.026. Epub 2011 Feb 18.
2011
AOU San Luigi di Orbassano

Guglielmelli T; Bringhen S; Rrodhe S; Gay F; Cavallo F; Berruti A; Montefusco V; Piro E; Benevolo G; Petrucci MT; Caravita T; Offidani M; Corradini P; Boccadoro M; Saglio G; Palumbo A;

Emerging targets for hematological malignancies. in Current opinion in drug discovery & development / Curr Opin Drug Discov Devel. 2010 Sep;13(5):548-58.
2010
AOU San Luigi di Orbassano

Cilloni D; Frassoni F; Saglio G;

Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. in The New England journal of medicine / N Engl J Med. 2010 Jun 17;362(24):2251-9. doi: 10.1056/NEJMoa0912614. Epub 2010 Jun 5.
2010
AOU San Luigi di Orbassano

Saglio G; Kim DW; Issaragrisil S; le Coutre P; Etienne G; Lobo C; Pasquini R; Clark RE; Hochhaus A; Hughes TP; Gallagher N; Hoenekopp A; Dong M; Haque A; Larson RA; Kantarjian HM;

Emerging drugs for chronic myeloid leukemia. in Expert opinion on emerging drugs / Expert Opin Emerg Drugs. 2010 Jun;15(2):175-84. doi: 10.1517/14728211003621220.
2010
AOU San Luigi di Orbassano

Cilloni D; Messa E; Rotolo A; Saglio G;

Proceedings of the Third Global Workshop on Chronic Myeloid Leukemia. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2010 Dec;10(6):443-51. doi: 10.3816/CLML.2010.n.077.
2010
AOU San Luigi di Orbassano

Saglio G; Kantarjian H; Holyoake T; Ranganathan A; Cortés JE;

2010
AOU San Luigi di Orbassano

Messa E; Carturan S; Maffè C; Pautasso M; Bracco E; Roetto A; Messa F; Arruga F; Defilippi I; Rosso V; Zanone C; Rotolo A; Greco E; Pellegrino RM; Alberti D; Saglio G; Cilloni D;

The best frontline therapy for CML: imatinib? in Clinical advances in hematology & oncology : H&O / Clin Adv Hematol Oncol. 2010 Apr;8(4):240-2.
2010
AOU San Luigi di Orbassano

Saglio G;

HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma. in International journal of hematology / Int J Hematol. 2009 Oct;90(3):392-396. doi: 10.1007/s12185-009-0418-y. Epub 2009 Sep 12.
2009
ASL Città di Torino
AOU San Luigi di Orbassano

Saglio G; Cilloni D; Morotti A; Allice T; Mete F; Familiari U; Bosa M; Nicoli P; Guerrasio A;

New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jun 15;877(18-19):1721-6. doi: 10.1016/j.jchromb
2009
AOU San Luigi di Orbassano

De Francia S; D'Avolio A; De Martino F; Pirro E; Baietto L; Siccardi M; Simiele M; Racca S; Saglio G; Di Carlo F; Di Perri G;

2009
AOU San Luigi di Orbassano

Guglielmelli T; Merlini R; Giugliano E; Saglio G;

2008
AOU San Luigi di Orbassano

Cilloni D; Messa F; Arruga F; Defilippi I; Gottardi E; Fava M; Carturan S; Catalano R; Bracco E; Messa E; Nicoli P; Diverio D; Sanz MA; Martinelli G; Lo-Coco F; Saglio G;

Acute myeloid leukemia induced by mitoxantrone treatment for aggressive multiple sclerosis. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2008 Jun;29(3):185-7. doi: 10.1007/s10072-008-0934-1. Epub 2008 Jul 9.
2008
AOU San Luigi di Orbassano

Capobianco M; Malucchi S; Ulisciani S; Fava C; Cambrin GR; Avonto L; Saglio G; Bertolotto A;

Molecular monitoring in patients with chronic myelogenous leukemia. in Current hematologic malignancy reports / Curr Hematol Malig Rep. 2008 Apr;3(2):65-71. doi: 10.1007/s11899-008-0011-0.
2008
AOU San Luigi di Orbassano

Saglio G; Ulisciani S; Fava M; Gottardi E; Cilloni D;

A young man with persistent eosinophilia. in Internal and emergency medicine / Intern Emerg Med. 2007 Jun;2(2):107-12. doi: 10.1007/s11739-007-0030-1.
2007
AOU San Luigi di Orbassano

Messa E; Cilloni D; Saglio G;

Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromes. in Annals of the New York Academy of Sciences / Ann N Y Acad Sci. 2006 Nov;1089:411-23. doi: 10.1196/annals.1386.030.
2006
AOU San Luigi di Orbassano

Cilloni D; Messa E; Messa F; Carturan S; Defilippi I; Arruga F; Rosso V; Catalano R; Bracco E; Nicoli P; Saglio G;

WT1 overexpression: a clinically useful marker in acute and chronic myeloid leukemias. in Hematology (Amsterdam, Netherlands) / Hematology. 2005;10 Suppl 1:76-8. doi: 10.1080/10245330512331390005.
2005
AOU San Luigi di Orbassano

Saglio G; Carturan S; Grillo S; Capella S; Arruga F; Defilippi I; Rosso V; Rauco M; Marina Liberati A; Cilloni D;

Myelodysplastic syndromes. in Annals of the New York Academy of Sciences / Ann N Y Acad Sci. 2004 Dec;1028:400-8. doi: 10.1196/annals.1322.048.
2004
AOU San Luigi di Orbassano

Cilloni D; Messa F; Carturan S; Arruga F; Defilippi I; Messa E; Gottardi E; Saglio G;

Abl: the prototype of oncogenic fusion proteins. in Cellular and molecular life sciences : CMLS / Cell Mol Life Sci. 2004 Dec;61(23):2897-911. doi: 10.1007/s00018-004-4271-0.
2004
AOU San Luigi di Orbassano

Saglio G; Cilloni D;

Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia. in Annals of the New York Academy of Sciences / Ann N Y Acad Sci. 2004 Dec;1028:423-31. doi: 10.1196/annals.1322.050.
2004
AOU San Luigi di Orbassano

Saglio G; Morotti A; Mattioli G; Messa E; Giugliano E; Volpe G; Rege-Cambrin G; Cilloni D;

2002
AOU San Luigi di Orbassano

Giugliano E; Rege-Cambrin G; Scaravaglio P; Wlodarska I; Emanuel B; Stul M; Serra A; Tonso A; Pini M; Saglio G; Hagemeijer A;

From genes to therapy: the case of Philadelphia chromosome-positive leukemias. in Annals of the New York Academy of Sciences / Ann N Y Acad Sci. 2002 Jun;963:306-12. doi: 10.1111/j.1749-6632.2002.tb04122.x.
2002
AOU San Luigi di Orbassano

Cilloni D; Guerrasio A; Giugliano E; Scaravaglio P; Volpe G; Rege-Cambrin G; Saglio G;

Extranodal Hodgkin lymphoma with renal, splenic and uterine involvement. A case report. in La Radiologia medica / Radiol Med. 2002 Jan-Feb;103(1-2):130-3.
2002
AOU San Luigi di Orbassano

Cataldi A; Sardo P; Ventilii G; Guerrasio A; Pilastrino C; Saglio G; Fava C;

2002
AOU San Luigi di Orbassano

Scaravaglio P; Guglielmelli T; Giugliano E; Marmont F; Audisio E; Gallo E; Saglio G; Rege-Cambrin G;

Patterns of cytokine expression in AIDS-related non-Hodgkin's lymphoma. in British journal of haematology / Br J Haematol. 1998 Oct;103(1):143-9. doi: 10.1046/j.1365-2141.1998.00927.x.
1998
AOU San Luigi di Orbassano

Pastore C; Gaidano G; Ghia P; Fassone L; Cilia AM; Gloghini A; Capello D; Buonaiuto D; Gonella S; Roncella S; Carbone A; Saglio G;

Outcome and lineage involvement in t(12;21) childhood acute lymphoblastic leukaemia. in British journal of haematology / Br J Haematol. 1997 May;97(2):460-2. doi: 10.1046/j.1365-2141.1997.312676.x.
1997
AOU San Luigi di Orbassano

Lanza C; Volpe G; Basso G; Gottardi E; Barisone E; Spinelli M; Ricotti E; Cilli V; Perfetto F; Madon E; Saglio G;

BCR/ABL transcripts and leukemia phenotype: an unsolved puzzle. in Leukemia & lymphoma / Leuk Lymphoma. 1997 Jul;26(3-4):281-6. doi: 10.3109/10428199709051777.
1997
AOU San Luigi di Orbassano

Saglio G; Pane F; Martinelli G; Guerrasio A;

Molecular pathways in low grade B-cell lymphoma. in Leukemia & lymphoma / Leuk Lymphoma. 1997 Dec;26 Suppl 1:107-13. doi: 10.3109/10428199709058607.
1997
AOU San Luigi di Orbassano

Gaidano G; Pastore C; Capello D; Cilli V; Saglio G;

Genetic lesions associated with blastic transformation of polycythemia vera and essential thrombocythemia. in Genes, chromosomes & cancer / Genes Chromosomes Cancer. 1997 Aug;19(4):250-5.
1997
AOU San Luigi di Orbassano

Gaidano G; Pastore C; Santini V; Nomdedeu J; Gamberi B; Capello D; Vischia F; Resegotti L; Mazza U; Ferrini PR; Lo Coco F; Saglio G;

Involvement of the cyclin-dependent kinase-4 inhibitor (CDKN2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukaemia. in British journal of haematology / Br J Haematol. 1995 Nov;91(3):625-9. doi: 10.1111/j.1365-2141.1995.tb05358.x.
1995
AOU San Luigi di Orbassano

Serra A; Gottardi E; Della Ragione F; Saglio G; Iolascon A;

Minimal residual disease detection in human leukemias: biologic and clinical significance. in Acta haematologica Polonica / Acta Haematol Pol. 1995;26(2 Suppl 1):19-24.
1995
AOU San Luigi di Orbassano

Saglio G;